You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

nis793

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreas Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in Boston (drug, radiation, procedure)

Recruiting
  • Pancreas Cancer
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Aug 19, 2022

Pancreatic Cancer, Resectable Pancreatic Cancer, Borderline Resectable Pancreatic Adenocarcinoma Trial in Boston (drug,

Not yet recruiting
  • Pancreatic Cancer
  • +3 more
  • Boston, Massachusetts
  • +1 more
Sep 16, 2022

Breast Cancer, Lung Cancer, Hepatocellular Cancer Trial in Worldwide (NIS793, PDR001)

Completed
  • Breast Cancer
  • +5 more
  • Nashville, Tennessee
  • +11 more
Jan 28, 2022

MDS Trial in Worldwide (MBG453, NIS793, canakinumab)

Recruiting
  • Myelodysplastic Syndromes
  • Duarte, California
  • +14 more
Jan 23, 2023

Primary Myelofibrosis, Myelofibrosis, PMF Trial (MBG453, NIS793, Spartalizumab)

Withdrawn
  • Primary Myelofibrosis
  • +4 more
  • (no location specified)
Mar 2, 2021

Metastatic Pancreatic Ductal Adenocarcinoma Trial in Worldwide (NIS793, Nab-paclitaxel, Gemcitabine)

Recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • NIS793
  • +3 more
  • Fayetteville, Arkansas
  • +122 more
Jan 27, 2023

Myelofibrosis Trial in Worldwide (Ruxolitinib, Siremadlin, Crizanlizumab)

Suspended
  • Myelofibrosis
  • Adelaide, South Australia, Australia
  • +37 more
Aug 18, 2022